RxDoctor Payments Data

Stacey Silvers, MD

Otolaryngology/Facial Plastic Surgery · New York, NYNPI 1487711727

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Aerin Medical Inc. at 48.0% of the total. Reporting peaked in 2020 at $11,969 and has fallen 86.5% since, to $1,620 in 2025. Among otolaryngology/facial plastic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,441in general payments, 2019–2025

Across 196 payments — averaging $216.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$20K
  • Intersect ENT, Inc.$8K
  • Medical Device Business Services, Inc.$5K
  • Optinose US, Inc.$4K
  • Sanofi$3K
  • Regeneron Healthcare Solutions, Inc.$773
  • plus $2K from 11 others
$567,215in research payments, 2019–2025

Across 98 payments — averaging $5787.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$395K
  • Intersect ENT, Inc.$133K
  • Stryker$12K
  • Optinose US, Inc.$11K
  • Eli Lilly$10K
  • Medtronic$4K
  • plus $2K from 1 others

What the payments were for

  • Consulting fees$21,83151%
  • Speaking & faculty fees$12,01128%
  • Travel & lodging$8052%
  • Food & beverage$7,76118%
  • Education$330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,441 in reported general payments places this provider in the 90th percentile of 48 otolaryngology/facial plastic surgery providers in New York.

See all otolaryngology/facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$408,970
Medicare patients
329
Services billed
1,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$50,583
Famotidine224$2,816
Ipratropium Bromide84$2,323
Omeprazole173$1,249
Gabapentin114$933
Azelastine Hcl22$795
Flunisolide16$748
Fluticasone Propionate71$631
Pantoprazole Sodium48$430
Mometasone Furoate14$278
Mupirocin25$179
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$161
Methylprednisolone19$158
Amitriptyline Hcl30$117
Levofloxacin11$60

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →